- Home
- Private Equity
- Sectors
- Healthcare
Healthcare
We partner with leading businesses to improve patient and consumer outcomes while accelerating time to market and managing cost through the value chain, from innovation and clinical trials to delivery of care.
Our focus
We invest in growth and support our portfolio through organic and acquisition-led development, helping our partners strategically transform their business during our ownership to create better outcomes and generate significant value.
Fundamental growth drivers include an ageing and more active population; greater access to healthcare globally; increasing use of data; advancements in biologics, minimally invasive medical devices and personalised medicine; and increasing patient engagement in healthcare and lifestyle decisions.
Track record
Havea
3i’s Rémi Carnimolla and Havea’s Nicolas Brodetsky discuss how the partnership helped Havea make five acquisitions in five years and double the size of the business.
Latest
-
31 Jan 2023
3i announces the sale of Q Holding’s Precision Components Division for proceeds of c.$172m
- Private Equity
- Healthcare
-
23 Jun 2022
3i enters into exclusive negotiations for the sale of Havea Group to BC Partners
- Private Equity
- Healthcare
-
25 Oct 2021
swissfillon, a leader in sterile filling of complex pharmaceuticals, joins 3i-backed ten23 health and enhances the combined company’s integrated offering to its customers
- Private Equity
- Healthcare



